Your browser doesn't support javascript.
loading
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper.
Kaiser, Martin; Pratt, Guy; Bygrave, Ceri; Bowles, Kristian; Stern, Simon; Jenner, Matthew.
Affiliation
  • Kaiser M; Department of Haematology, The Royal Marsden Hospital, London, UK.
  • Pratt G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Bygrave C; Department of Haematology, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK.
  • Bowles K; Department of Haematology, University Hospital of Wales, Cardiff, UK.
  • Stern S; Department of Haematology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Jenner M; Department of Haematology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, UK.
Br J Haematol ; 2024 Jul 01.
Article in En | MEDLINE | ID: mdl-38952046
ABSTRACT
This Good Practice Paper provides recommendations for the diagnosis and initial management of transplant-eligible high-risk myeloma patients. It describes recent updates to the genetic diagnostics of high-risk myeloma and provides recommendations for treatment on the basis of recent prospective clinical trial evidence.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Type: Article